Products
AH-7921 is not on the market as a drug. It has been semi-legally and illegally traded on the black market and abused as an intoxicant since 2012. AH-7921 was patented in 1976 by Allen and Hanburys Ltd.
Structure and properties
AH-7921 (C16H22Cl2N2O, Mr = 329.3 g/mol) is structurally different from classical opioids such as morphine. It has a benzamide structure and is related to U-47700.
Effects
AH-7921 has psychotropic, analgesic, depressant, and euphoric properties. The effects are due to binding to μ-opioid receptors in the central nervous system.
Indications
No medical indications exist.
Abuse
As an intoxicant.
Adverse effects
Because of the life-threatening adverse effects, abuse is strongly discouraged. Opioids can cause respiratory depression, respiratory paralysis, hypotension, and circulatory failure, especially in overdose. Several deaths associated with AH-7921 have been reported.
